Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

NCT02149342 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratoses

Interventions

DRUG: Hexylaminolaevulinate cream
DRUG: Methylaminolaevulinate cream

Sponsor

Joint Authority for Päijät-Häme Social and Health Care

Collaborators

[object Object]